parent_name,parent_smiles,parent_inchi,metabolite_name,metabolite_smiles,metabolite_inchi,enzymes,fingerprint_similarity,reaction_type
Calcitriol,C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CCCC(C)(C)O)CC(O)CC1O,GMRQFYUYWCNGIN-NKMMMXOESA-N,Calcitroic acid,C=C1C(=CC=C2CCCC3(C)C2CCC3C(C)CC(=O)O)CC(O)CC1O,MBLYZRMZFUWLOZ-WLWRUGSRSA-N,,0.91,
Cladribine,NC1=C2N=CN(C3CC(O)C(CO)O3)C2=NC(Cl)=N1,PTOAARAWEBMLNO-KVQBGUIXSA-N,2-chloro-2'-deoxyadenosine-5'-triphosphate,NC1=C2N=CN(C3CC(O)C(COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O3)C2=NC(Cl)=N1,PZCJNHCKXRBBNN-KVQBGUIXSA-N,,0.86,
Cabergoline,C=CCN1CC(C(=O)N(CCCN(C)C)C(=O)NCC)CC2C3=C4C(=CNC4=CC=C3)CC21,KORNTPPJEAJQIU-KJXAQDMKSA-N,6-allyl-8b-carboxy-ergoline,C=CCN1CC(C(=O)O)CC2C3=C4C(=CNC4=CC=C3)CC21,YAICYXFUKKMAKO-DBQWNMKUSA-N,,0.83,
Atomoxetine,CNCCC(OC1=CC=CC=C1C)C1=CC=CC=C1,VHGCDTVCOLNTBX-QGZVFWFLSA-N,4-hydroxyatomoxetine,CNCCC(OC1=CC=C(O)C=C1C)C1=CC=CC=C1,PPXQPRLGNSJNJM-QGZVFWFLSA-N,Cytochrome P450 2D6,0.93,
Morphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)C=CC3C1C5,BQJCRHHNABKAKU-KBQPJGBKSA-N,Codeine,COC1=CC=C2CC3C4C=CC(O)C5OC1=C2C45CCN3C,OROGSEYTTFOCAN-DNJOTXNNSA-N,,0.99,
Ropivacaine,CCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C,ZKMNUMMKYBVTFN-HNNXBMFYSA-N,3-hydroxyropivacaine,CCCN1CCCCC1C(=O)NC1=C(C)C(O)=CC=C1C,IXOVDWXTIIYVOJ-AWEZNQCLSA-N,Cytochrome P450 1A2,0.83,
Omeprazole,COC1=CC2=C(C=C1)N=C(S(=O)CC1=NC=C(C)C(OC)=C1C)N2,SUBDBMMJDZJVOS-UHFFFAOYSA-N,5-Hydroxyomeprazole,COC1=CC2=C(C=C1)N=C(S(=O)CC1=NC=C(CO)C(OC)=C1C)N2,CMZHQFXXAAIBKE-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19, Cytochrome P450 3A4",0.94,
Mupirocin,CC(=CC(=O)OCCCCCCCCC(=O)O)CC1OCC(CC2OC2C(C)C(C)O)C(O)C1O,MINDHVHHQZYEEK-HBBNESRFSA-N,Monic acid,CC(=CC(=O)O)CC1CCC(CC2OC2C(C)C(C)O)C(O)C1O,MUWNEQMGMLXEFO-CXSJRMNRSA-N,,0.59,
Allopurinol,OC1=NC=NC2=C1C=NN2,OFCNXPDARWKPPY-UHFFFAOYSA-N,oxypurinol,O=C1NC(=O)C2=C(NN=C2)N1,HXNFUBHNUDHIGC-UHFFFAOYSA-N,,0.43,
Pefloxacin,CCN1C=C(C(=O)O)C(=O)C2=CC(F)=C(N3CCN(C)CC3)C=C21,"InChI=1S/C17H20FN3O3/c1-3-20-10-12(17(23)24)16(22)11-8-13(18)15(9-14(11)20)21-6-4-19(2)5-7-21/h8-10H,3-7H2,1-2H3,(H,23,24)",Norfloxacin,CCN1C=C(C(=O)O)C(=O)C2=CC(F)=C(N3CCNCC3)C=C21,OGJPXUAPXNRGGI-UHFFFAOYSA-N,,0.99,
Nitazoxanide,CC(=O)OC1=CC=CC=C1C(=O)NC1=NC=C([N+](=O)[O-])S1,YQNQNVDNTFHQSW-UHFFFAOYSA-N,Desacetyl-nitazoxanide,O=C(NC1=NC=C([N+](=O)[O-])S1)C1=CC=CC=C1O,FDTZUTSGGSRHQF-UHFFFAOYSA-N,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,0.83,
Rofecoxib,CS(=O)(=O)C1=CC=C(C2=C(C3=CC=CC=C3)C(=O)OC2)C=C1,RZJQGNCSTQAWON-UHFFFAOYSA-N,5-Hydroxyrofecoxib,CS(=O)(=O)C1=CC=C(C2=C(C3=CC=CC=C3)C(=O)OC2O)C=C1,NCBVUSNBLYMFPP-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 3A4",0.85,
Propranolol,CC(C)NCC(O)COC1=CC=CC2=C1C=CC=C2,AQHHHDLHHXJYJD-UHFFFAOYSA-N,N-desisopropylpropranolol,NCC(O)COC1=CC=CC2=CC=CC=C12,ZFMCITCRZXLMDJ-UHFFFAOYSA-N,Cytochrome P450 1A2,0.86,
Valdecoxib,CC1=C(C2=CC=C(S(N)(=O)=O)C=C2)C(C2=CC=CC=C2)=NO1,LNPDTQAFDNKSHK-UHFFFAOYSA-N,Valdecoxib metabolite M2,CC1=C(C2=CC=C(S(=O)(=O)NO)C=C2)C(C2=CC=CC=C2)=NO1,ONTHNDYCEKOFIC-UHFFFAOYSA-N,,0.96,
Furazolidone,O=C1OCCN1N=CC1=CC=C([N+](=O)[O-])O1,"InChI=1S/C8H7N3O5/c12-8-10(3-4-15-8)9-5-6-1-2-7(16-6)11(13)14/h1-2,5H,3-4H2/b9-5+",3-amino-2-oxazolidone,NN1CCOC1=O,KYCJNIUHWNJNCT-UHFFFAOYSA-N,,0.21,
Rocuronium,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2OC(C)=O)CCCC1,YXRDKMPIGHSVRX-OOJCLDBCSA-N,17-desacetyl-rocuronium,C=CC[N+]1(C2CC3C4CCC5CC(O)C(N6CCOCC6)CC5(C)C4CCC3(C)C2O)CCCC1,KJLODZNGZVUFDC-DSBFZBMTSA-M,,0.78,
Etodolac,CCC1=C2NC3=C(CCOC3(CC)CC(=O)O)C2=CC=C1,NNYBQONXHNTVIJ-UHFFFAOYSA-N,6-Hydroxyetodolac,CCC1=CC(O)=CC2=C1NC1=C2CCOC1(CC)CC(=O)O,GQHWDDBALZVXBU-UHFFFAOYSA-N,Cytochrome P450 2C9,0.94,
Roxithromycin,CCC1OC(=O)C(C)C(OC2CC(C)(OC)C(O)C(C)O2)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C(=NOCOCCOC)C(C)C(O)C1(C)O,"InChI=1S/C41H76N2O15/c1-15-29-41(10,49)34(45)24(4)31(42-53-21-52-17-16-50-13)22(2)19-39(8,48)36(58-38-32(44)28(43(11)12)18-23(3)54-38)25(5)33(26(6)37(47)56-29)57-30-20-40(9,51-14)35(46)27(7)55-30/h22-30,32-36,38,44-46,48-49H,15-21H2,1-14H3/b42-31+/t22-,23-,24+,25+,26-,27+,28+,29-,30+,32-,33+,34-,35+,36-,38+,39-,40-,41-/m1/s1",descladinose roxithromycin,CCC1OC(=O)C(C)C(O)C(C)C(OC2OC(C)CC(N(C)C)C2O)C(C)(O)CC(C)C(=NOCOCCOC)C(C)C(O)C1(C)O,BNZRPTCUAOMSSH-LKPWEDHSSA-N,,0.95,
Perindopril,CCCC(NC(C)C(=O)N1C(C(=O)O)CC2CCCCC21)C(=O)OCC,IPVQLZZIHOAWMC-QXKUPLGCSA-N,Perindopril Acyl-beta-D-glucuronide,CCCC(NC(C)C(=O)N1C(C(=O)OC2OC(C(=O)O)C(O)C(O)C2O)CC2CCCCC21)C(=O)OCC,VEYBPHDESXGJIN-VEYQHAJCSA-N,,0.63,
Candesartan cilexetil,CCOC1=NC2=C(C(C(=O)OC(C)OC(=O)OC3CCCCC3)=CC=C2)N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,GHOSNRCGJFBJIB-UHFFFAOYSA-N,Candesartan,CCOC1=NC2=CC=CC(C(=O)O)=C2N1CC1=CC=C(C2=CC=CC=C2C2=NN=NN2)C=C1,"InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)",,0.88,
Prednisolone,CC12C=CC(=O)C=C1CCC1C2C(O)CC2(C)C1CCC2(O)C(=O)CO,OIGNJSKKLXVSLS-VWUMJDOOSA-N,Prednisone,CC12C=CC(=O)C=C1CCC1C2C(=O)CC2(C)C1CCC2(O)C(=O)CO,XOFYZVNMUHMLCC-ZPOLXVRWSA-N,,0.83,
Granisetron,CN1C2CCCC1CC(NC(=O)C1=NN(C)C3=C1C=CC=C3)C2,MFWNKCLOYSRHCJ-BTTYYORXSA-N,9'-desmethylgranisetron,CN1C2CCCC1CC(NC(=O)C1=NNC3=CC=CC=C13)C2,GHVQAOGYNZNTIA-CLLJXQQHSA-N,"Cytochrome P450 3A4, Cytochrome P450 1A1",0.85,
Fenofibrate,CC(C)OC(=O)C(C)(C)OC1=CC=C(C(=O)C2=CC=C(Cl)C=C2)C=C1,YMTINGFKWWXKFG-UHFFFAOYSA-N,Fenofibric acid,CC(C)(OC1=CC=C(C(=O)C2=CC=C(Cl)C=C2)C=C1)C(=O)O,MQOBSOSZFYZQOK-UHFFFAOYSA-N,Liver carboxylesterase 1,0.84,
Emedastine,CCOCCN1C(N2CCCN(C)CC2)=NC2=CC=CC=C21,KBUZBQVCBVDWKX-UHFFFAOYSA-N,5-hydroxyemedastine,CCOCCN1C(N2CCCN(C)CC2)=NC2=C1C=CC(O)=C2,JNLXTCQXMDMAOC-UHFFFAOYSA-N,,0.92,
Fluvastatin,CC(C)N1C(C=CC(O)CC(O)CC(=O)O)=C(C2=CC=C(F)C=C2)C2=CC=CC=C21,FJLGEFLZQAZZCD-VAWYXSNFSA-N,6-Hydroxyfluvastatin,CC(C)N1C(C=CC(O)CC(O)CC(=O)O)=C(C2=CC=C(F)C=C2)C2=CC=C(O)C=C21,WSYBZSUCJJHTIP-FDGXHLLTSA-N,Cytochrome P450 2C9,0.95,
Itraconazole,CCC(C)N1N=CN(C2=CC=C(N3CCN(C4=CC=C(OCC5COC(CN6C=NC=N6)(C6=C(Cl)C=C(Cl)C=C6)O5)C=C4)CC3)C=C2)C1=O,VHVPQPYKVGDNFY-ZPGVKDDISA-N,hydroxyitraconazole,CC(O)C(C)N1N=CN(C2=CC=C(N3CCN(C4=CC=C(OCC5COC(CN6C=NC=N6)(C6=C(Cl)C=C(Cl)C=C6)O5)C=C4)CC3)C=C2)C1=O,ISJVOEOJQLKSJU-UHFFFAOYSA-N,,0.98,
Naloxone,C=CCN1CCC23C4=C5OC2C(=O)CCC3(O)C1CC4=CC=C5O,UZHSEJADLWPNLE-GRGSLBFTSA-N,noroxymorphone,O=C1CCC2(O)C3CC4=C5C(=C(O)C=C4)OC1C52CCN3,HLMSIZPQBSYUNL-IPOQPSJVSA-N,,0.98,
Estazolam,ClC1=CC2=C(C=C1)N1C=NN=C1CN=C2C1=CC=CC=C1,CDCHDCWJMGXXRH-UHFFFAOYSA-N,4-hydroxy-estazolam,OC1N=C(C2=CC=CC=C2)C2=C(C=CC(Cl)=C2)N2C=NN=C12,LJIJJCXFWLORDQ-UHFFFAOYSA-N,,0.88,
Ketamine,CNC1(C2=CC=CC=C2Cl)CCCCC1=O,YQEZLKZALYSWHR-UHFFFAOYSA-N,Norketamine,NC1(C2=C(Cl)C=CC=C2)CCCCC1=O,BEQZHFIKTBVCAU-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2B6, Cytochrome P450 3A4",0.84,
Guanine,NC1=NC(=O)C2=C(N=CN2)N1,"InChI=1S/C5H5N5O/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",Xanthine,O=C1NC(=O)C2=C(N=CN2)N1,LRFVTYWOQMYALW-UHFFFAOYSA-N,Guanine deaminase,0.61,
Lumiracoxib,CC1=CC=C(NC2=C(Cl)C=CC=C2F)C(CC(=O)O)=C1,"InChI=1S/C15H13ClFNO2/c1-9-5-6-13(10(7-9)8-14(19)20)18-15-11(16)3-2-4-12(15)17/h2-7,18H,8H2,1H3,(H,19,20)",Lumiracoxib metabolite M21,O=C(O)CC1=CC(CO)=CC=C1NC1=C(Cl)C=CC=C1F,PREBINJQDJNORC-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C19",0.94,
Lumiracoxib metabolite M21,O=C(O)CC1=CC(CO)=CC=C1NC1=C(Cl)C=CC=C1F,PREBINJQDJNORC-UHFFFAOYSA-N,Lumiracoxib metabolite M9,O=C(O)CC1=CC(CO)=CC=C1NC1=C(Cl)C=C(O)C=C1F,CTTBSLWMGLKKJO-UHFFFAOYSA-N,,0.88,
Antipyrine,CC1=CC(=O)N(C2=CC=CC=C2)N1C,VEQOALNAAJBPNY-UHFFFAOYSA-N,Edaravone,CC1=NN(C2=CC=CC=C2)C(=O)C1,QELUYTUMUWHWMC-UHFFFAOYSA-N,"Cytochrome P450 2C9, Cytochrome P450 2C8, Cytochrome P450 2C19, Cytochrome P450 1A2",0.16,
Diamorphine,CC(=O)OC1=C2OC3C(OC(C)=O)C=CC4C5CC(=C2C43CCN5C)C=C1,GVGLGOZIDCSQPN-PVHGPHFFSA-N,6-Monoacetylmorphine,CC(=O)OC1C=CC2C3CC4=C5C(=C(O)C=C4)OC1C52CCN3C,JJGYGPZNTOPXGV-SSTWWWIQSA-N,"Liver carboxylesterase 1, Cocaine esterase",0.99,
Ursodeoxycholic acid,CC(CCC(=O)O)C1CCC2C3C(O)CC4CC(O)CCC4(C)C3CCC12C,RUDATBOHQWOJDD-UZVSRGJWSA-N,Lithocholic acid,CC(CCC(=O)O)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C,,,0.87,
Estriol,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(O)C2O,PROQIPRRNZUXQM-ZXXIGWHRSA-N,Estriol-16-Glucuronide,CC12CCC3C4=C(C=C(O)C=C4)CCC3C1CC(OC1OC(C(=O)O)C(O)C(O)C1O)C2O,FQYGGFDZJFIDPU-JRSYHJKYSA-N,,0.65,
Debrisoquine,N=C(N)N1CCC2=CC=CC=C2C1,"InChI=1S/C10H13N3/c11-10(12)13-6-5-8-3-1-2-4-9(8)7-13/h1-4H,5-7H2,(H3,11,12)",4-Hydroxydebrisoquine,N=C(N)N1CC2=C(C=CC=C2)C(O)C1,,Cytochrome P450 2D6,0.74,
Trabectedin,COC1=CC2=C(C=C1O)CCNC21CSC2C3=C(OC(C)=O)C(C)=C4OCOC4=C3C(COC1=O)N1C(O)C3CC4=CC(C)=C(OC)C(O)=C4C(C21)N3C,PKVRCIRHQMSYJX-AIFWHQITSA-N,Trabectedin metabolite M9,COC1=CC2=C(C=C1O)CCNC21CSC2C3=C(OC(C)=O)C(C)=C(O)C(O)=C3C(COC1=O)N1C(O)C3CC4=CC(C)=C(OC)C(O)=C4C(C21)N3C,WMQKTHWOQUOPDO-BUURXMNCSA-N,,0.99,
Lasofoxifene,OC1=CC=C2C(=C1)CCC(C1=CC=CC=C1)C2C1=CC=C(OCCN2CCCC2)C=C1,GXESHMAMLJKROZ-IAPPQJPRSA-N,7-hydroxy-lasofoxifene (7-OHLAS),OC1=C(O)C=C2C(=C1)CCC(C1=CC=CC=C1)C2C1=CC=C(OCCN2CCCC2)C=C1,SRFOURLTANIWOZ-YWEHKCAJSA-N,"Cytochrome P450 3A5, Cytochrome P450 2D6",0.94,
Ambrisentan,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(C)=N1)C(=O)O,OUJTZYPIHDYQMC-LJQANCHMSA-N,Ambrisentan glucuronide,COC(C1=CC=CC=C1)(C1=CC=CC=C1)C(OC1=NC(C)=CC(C)=N1)C(=O)OC1OC(C(=O)O)C(O)C(O)C1O,QBHJFBFSJYTXDX-KFXNSFBMSA-N,"UDP-glucuronosyltransferase 2B7, UDP-glucuronosyltransferase 1-9, UDP-glucuronosyltransferase 1-3",0.72,
Isavuconazonium,CNCC(=O)OCC1=C(N(C)C(=O)OC(C)[N+]2=CN(CC(O)(C3=C(F)C=CC(F)=C3)C(C)C3=NC(C4=CC=C(C#N)C=C4)=CS3)N=C2)N=CC=C1,RSWOJTICKMKTER-QXLBVTBOSA-N,Isavuconazole,CC(C1=NC(C2=CC=C(C#N)C=C2)=CS1)C(O)(CN1C=NC=N1)C1=C(F)C=CC(F)=C1,DDFOUSQFMYRUQK-RCDICMHDSA-N,Cholinesterase,0.82,
Artemether,COC1OC2OC3(C)CCC4C(C)CCC(C1C)C24OO3,SXYIRMFQILZOAM-HVNFFKDJSA-N,Alpha-dihydroartemisinin,CC1CCC2C(C)C(O)OC3OC4(C)CCC1C32OO4,BJDCWCLMFKKGEE-KXTPALSWSA-N,,0.99,
Aceclofenac,O=C(O)COC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,MNIPYSSQXLZQLJ-UHFFFAOYSA-N,Diclofenac,O=C(O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl,DCOPUUMXTXDBNB-UHFFFAOYSA-N,,0.85,
Difluprednate,CCCC(=O)OC1(C(=O)COC(C)=O)CCC2C3CC(F)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,WYQPLTPSGFELIB-JTQPXKBDSA-N,Hydroxyfluoroprednisolone butyrate,CCCC(=O)OC1(C(=O)CO)CCC2C3CC(O)C4=CC(=O)C=CC4(C)C3(F)C(O)CC21C,KODYJDILUXBYNG-MXHGPKCJSA-N,,0.86,
Cetyl alcohol,CCCCCCCCCCCCCCCCO,BXWNKGSJHAJOGX-UHFFFAOYSA-N,Palmitic Acid,CCCCCCCCCCCCCCCC(=O)O,IPCSVZSSVZVIGE-UHFFFAOYSA-N,Alcohol dehydrogenase [NADP(+)],0.52,
Gamolenic acid,CCCCCC=CCC=CCC=CCCCCC(=O)O,VZCCETWTMQHEPK-QNEBEIHSSA-N,Dihomo-gamma-linolenic acid,CCCCCC=CCC=CCC=CCCCCCCC(=O)O,"InChI=1S/C20H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20(21)22/h6-7,9-10,12-13H,2-5,8,11,14-19H2,1H3,(H,21,22)/b7-6-,10-9-,13-12-","Elongation of very long chain fatty acids protein 5, Elongation of very long chain fatty acids protein 4",0.85,
Clascoterone,CCC(=O)OC1(C(=O)CO)CCC2C3CCC4=CC(=O)CCC4(C)C3CCC21C,GPNHMOZDMYNCPO-PDUMRIMRSA-N,Cortexolone,CC12CCC(=O)C=C1CCC1C2CCC2(C)C1CCC2(O)C(=O)CO,,Carboxylesterase,0.77,
Molnupiravir,CC(C)C(=O)OCC1OC(N2C=CC(=NO)NC2=O)C(O)C1O,HTNPEHXGEKVIHG-QCNRFFRDSA-N,N4-Hydroxycytidine,O=C1N=C(NO)C=CN1C1OC(CO)C(O)C1O,"InChI=1S/C9H13N3O6/c13-3-4-6(14)7(15)8(18-4)12-2-1-5(11-17)10-9(12)16/h1-2,4,6-8,13-15,17H,3H2,(H,10,11,16)/t4-,6-,7-,8-/m1/s1",,0.73,
Benzoic acid,O=C(O)C1=CC=CC=C1,WPYMKLBDIGXBTP-UHFFFAOYSA-N,Hippuric acid,O=C(O)CNC(=O)C1=CC=CC=C1,QIAFMBKCNZACKA-UHFFFAOYSA-N,,0.28,
Nicotine imine,C[N+]1=CCCC1C1=CC=CN=C1,GTQXYYYOJZZJHL-UHFFFAOYSA-N,Cotinine,CN1C(=O)CCC1C1=CN=CC=C1,UIKROCXWUNQSPJ-UHFFFAOYSA-N,Aldehyde oxidase,0.5,
12-Hydroxynevirapine,OCC1=C2N=C(O)C3=C(N=CC=C3)N(C3CC3)C2=NC=C1,SEBABOMFNCVZGF-UHFFFAOYSA-N,12-hydroxynevirapine glucuronide,CC1=C2N=C(OC3OC(C(=O)O)C(O)C(O)C3O)C3=C(N=CC=C3)N(C3CC3O)C2=NC=C1,UVZMQJUCOZEMQZ-RDPCRGLVSA-N,,0.76,
Phenytoin arene-oxide,O=C1NC(=O)C(C2=CC3OC3C=C2)(C2=CC=CC=C2)N1,WBRFFCOFWKCXFD-UHFFFAOYSA-N,Phenytoin dihydrodiol,O=C1NC(=O)C(C2=CC(O)C(O)C=C2)(C2=CC=CC=C2)N1,FEEKFEKCXIDMIS-UHFFFAOYSA-N,"Cytochrome P450 1A2, Cytochrome P450 2A6, Cytochrome P450 2C19, Cytochrome P450 2C8, Cytochrome P450 2C9, Cytochrome P450 2D6, Cytochrome P450 2E1, Cytochrome P450 3A4, Epoxide hydrolase 1",0.96,
Methoxyzolpidem derivative (M3),CC1=CN2C(CC(=O)N(C)C)=C(C3=CC=C(CO)C=C3)N=C2C=C1,MKLBTYQCCMFWQI-UHFFFAOYSA-N,Zolpidem carboxylic acid derivative (M1),CC1=CN2C(CC(=O)N(C)C)=C(C3=CC=C(C(=O)O)C=C3)N=C2C=C1,FELZONDEFBLTSP-UHFFFAOYSA-N,,0.97,
2-hydroxyimipramine,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(O)=CC=C21,ROTCPJFWLNDKHU-UHFFFAOYSA-N,2-hydroxy-imipramine glucuronide,CN(C)CCCN1C2=CC=CC=C2CCC2=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CC=C21,CBEJFHYWZSCYSD-LYVDORBWSA-N,,0.56,
"Rofecoxib-erythro-3,4-dihydrohydroxy acid",CS(=O)(=O)C1=CC=C(C(CO)C(C(=O)O)C2=CC=CC=C2)C=C1,BBBDYOCLJIKLKC-JKSUJKDBSA-N,cis-Dihydrorofecoxib,CS(=O)(=O)C1=CC=C(C2COC(=O)C2C2=CC=CC=C2)C=C1,PHCFUFKRCHEUTJ-CVEARBPZSA-N,,0.86,
Dihydro-5-hydroxyrofecoxib,CS(=O)(=O)C1=CC=C(C2C(O)OC(=O)C2C2=CC=CC=C2)C=C1,KETRNDQFHQCNAX-UHFFFAOYSA-N,"Rofecoxib-threo-3,4-dihydrohydroxy acid",CS(=O)(=O)C1=CC=C(C(CO)C(C(=O)O)C2=CC=CC=C2)C=C1,BBBDYOCLJIKLKC-HZPDHXFCSA-N,,0.75,
Zafirlukast metabolite M1,COC1=C(CC2=CN(C)C3=C2C=C(N)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,HNBZIIQASMYNPG-UHFFFAOYSA-N,Zafirlukast metabolite M2,COC1=C(CC2=CN(C)C3=C2C=C(NC(C)=O)C=C3)C=CC(C(=O)NS(=O)(=O)C2=CC=CC=C2C)=C1,XZEKBYKKJYHZAZ-UHFFFAOYSA-N,"Arylamine N-acetyltransferase 1, Arylamine N-acetyltransferase 2",0.95,
Hypoxanthine,O=C1N=CNC2=C1NC=N2,FDGQSTZJBFJUBT-UHFFFAOYSA-N,Xanthine,O=C1NC(=O)C2=C(N=CN2)N1,LRFVTYWOQMYALW-UHFFFAOYSA-N,Xanthine dehydrogenase/oxidase,0.76,
4-Chlorobenzenesulfonylurea,NC(=O)NS(=O)(=O)C1=CC=C(Cl)C=C1,AZEPYUPSYWCRBG-UHFFFAOYSA-N,4-Chlorobenzenesulfonamide,NS(=O)(=O)C1=CC=C(Cl)C=C1,HHHDJHHNEURCNV-UHFFFAOYSA-N,,0.62,
Nateglinide metabolite M2/M3,CC(CO)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,GMHTWYIGIMINLF-OKEQZYBDSA-N,Nateglinide metabolite M11/M12,CC(O)(CO)C1CCC(C(=O)NC(CC2=CC=CC=C2)C(=O)O)CC1,IQRZZFUXRZWAPZ-XZZQLLPFSA-N,,0.91,
5'-hydroxymethyl meloxicam,CN1C(C(O)=NC2=NC=C(CO)S2)=C(O)C2=CC=CC=C2S1(=O)=O,LOOSAJMIEADILV-UHFFFAOYSA-N,5'-carboxy meloxicam,CN1C(C(O)=NC2=NC=C(C(=O)O)S2)=C(O)C2=CC=CC=C2S1(=O)=O,MTQQFYLGAZXHTB-UHFFFAOYSA-N,"Cytochrome P450 3A4, Cytochrome P450 2C9",0.98,
Alpha-methyldopamine,CC(N)CC1=CC(O)=C(O)C=C1,KSRGADMGIRTXAF-UHFFFAOYSA-N,3-O-methyl-alpha-methyldopamine,COC1=C(O)C=CC(CC(C)N)=C1,GPBOYXOSSQEJBH-UHFFFAOYSA-N,Catechol O-methyltransferase,0.78,
2-phthalimidoglutaramic acid,NC(=O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,JMKLVQRQCLMCIN-UHFFFAOYSA-N,2-phthalimidoglutaric acid,O=C(O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,FEFFSKLJNYRHQN-UHFFFAOYSA-N,,0.93,
4-phthalimidoglutaramic acid,NC(=O)C(CCC(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,CUBMYGDAHSAJPJ-UHFFFAOYSA-N,2-phthalimidoglutaric acid,O=C(O)CCC(C(=O)O)N1C(=O)C2=C(C=CC=C2)C1=O,FEFFSKLJNYRHQN-UHFFFAOYSA-N,,0.81,
Vortioxetine Metabolite 1,CC1=C(SC2=CC=CC=C2N2CC[NH2+]CC2)C=CC(CO)=C1,INVFGIUFVDSKAT-UHFFFAOYSA-O,M0,CC1=C(SC2=CC=CC=C2N2CC[NH2+]CC2)C=CC(C(=O)O)=C1,ROOVDZHALVSNIQ-UHFFFAOYSA-O,Cytochrome P450 2D6,0.91,
Eslicarbazepine [(S)-licarbazepine],NC(=O)N1C2=CC=CC=C2CC(O)C2=C1C=CC=C2,BMPDWHIDQYTSHX-CQSZACIVSA-N,Oxcarbazepine,NC(=O)N1C2=CC=CC=C2CC(=O)C2=C1C=CC=C2,CTRLABGOLIVAIY-UHFFFAOYSA-N,,0.64,
Sennidin A,O=C(O)C1=CC(O)=C2C(=O)C3=C(O)C=CC=C3C(C3C4=CC=CC(O)=C4C(=O)C4=C(O)C=C(C(=O)O)C=C43)C2=C1,JPMRHWLJLNKRTJ-UHFFFAOYSA-N,Rheinanthrone,O=C(O)C1=CC2CC3=C(C(=O)C2C(O)=C1)C(O)=CC=C3,RRMMJVMTHXZXEG-UHFFFAOYSA-N,Beta-glucosidase,0.36,
Adefovir monophosphate,NC1=C2N=CN(CCOCP(=O)(O)OP(=O)(O)O)C2=NC=N1,VQIHLCFUFNQXPS-UHFFFAOYSA-N,Adefovir Diphosphate,NC1=C2N=CN(CCOCP(=O)(O)OP(=O)(O)OP(=O)(O)O)C2=NC=N1,MELHEUHXJKQZNC-UHFFFAOYSA-N,"Nucleoside diphosphate kinase A, Nucleoside diphosphate kinase B",0.91,
Nitroso-sulfamethoxazole,CC1=CC(NS(=O)(=O)C2=CC=C(N=O)C=C2)=NO1,GHNQGDUYHCZZPT-UHFFFAOYSA-N,Sulfamethoxazole GSH conjugate,CC1=CC(NS(=O)(=O)C2=CC=C(NS(=O)SCC(NC(=O)CCC(N)C(=O)O)C(=O)NCC(=O)O)C=C2)=NO1,MWMVGJQLWMXBGZ-JTWSNUQWSA-N,,0.55,
2-(o-carboxybenzamido)glutaramic acid,NC(=O)CCC(NC(=O)C1=C(C(=O)O)C=CC=C1)C(=O)O,ZIMWCUUEMGFXNW-UHFFFAOYSA-N,L-Glutamine,NC(=O)CCC(N)C(=O)O,ZDXPYRJPNDTMRX-VKHMYHEASA-N,,0.2,
4-(o-carboxybenzamido)glutaramic acid,NC(=O)C(CCC(=O)O)NC(=O)C1=C(C(=O)O)C=CC=C1,JOAOKNHCUKCBBE-UHFFFAOYSA-N,Isoglutamine,NC(=O)C(N)CCC(=O)O,"InChI=1S/C5H10N2O3/c6-3(5(7)10)1-2-4(8)9/h3H,1-2,6H2,(H2,7,10)(H,8,9)/t3-/m0/s1",,0.2,
5’-Deoxy-5-fluorouridine (5'DFUR),CC1OC(N2C=C(F)C(=O)NC2=O)C(O)C1O,ZWAOHEXOSAUJHY-ZIYNGMLESA-N,5-fluorouracil,O=C1NC=C(F)C(=O)N1,GHASVSINZRGABV-UHFFFAOYSA-N,"Thymidine phosphorylase, Uridine phosphorylase 1, Uridine phosphorylase 2",0.2,
M7-B (Odanacatib),CC(F)(C=O)CC(NC(C1=CC=C(C2=CC=C(S(C)(=O)=O)C=C2)C=C1)C(F)(F)F)C(=O)NC1(C#N)CC1,HJVPPQGUHTYYIX-MMBKUXRPSA-N,M7-A (Odanacatib),CC1(F)CC(C(=O)NC2(C#N)CC2)N(C(C2=CC=C(C3=CC=C(S(C)(=O)=O)C=C3)C=C2)C(F)(F)F)C1O,DJMACUHRDOYUAX-CJLMEKCWSA-N,,0.69,
(R)-1-(4-Methoxyphenyl)propan-2-amine,COC1=CC=C(CC(C)N)C=C1,,,CC(N)CC1=CC=C(O)C=C1,,CYP2D6,0.83,O-Demethylation
Rabeprazole (rabeprazole_thioether),COCCCOC1=CC=NC(CSC2=NC3=CC=CC=C3N2)=C1C,,Rabeprazole,COCCCOC1=CC=NC(CS(=O)C2=NC3=CC=CC=C3N2)=C1C,,CYP1A2;CYP2A6;CYP2C9;CYP2C19;CYP2D6;CYP2E1;CYP3A4,0.86,S-OXIDATION
"3-(cyclohexylmethyl)-1,7,8-trimethylpurine-2,6-dione",CC1=NC2=C(C(=O)N(C)C(=O)N2CC2CCCCC2)N1C,,,CC1=NC2=C(C(=O)N(C)C(=O)N2CC2CCCC(O)C2)N1C,,CYP1A2,0.97,Aliphatic Hydroxylation
(-)-thalidomide,O=C1N=C(O)CCC1N1C(=O)C2=CC=CC=C2C1=O,,"cis, trans-5'-OH-thalidomide",O=C1N=C(O)C(N2C(=O)C3=CC=CC=C3C2=O)CC1O,,CYP2C19,0.62,Alpha hydroxylation of carbonyl group
(-)-zileuton,CC(C1=CC2=CC=CC=C2S1)N(O)C(=N)O,,Zileuton sulfoxide,CC(C1=CC2=CC=CC=C2S1=O)N(O)C(=N)O,,CYP3A4,0.25,Thiohene S-oxidation
"(2s,5s)-troglitazone",CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC4SC(=O)N=C4O)C=C3)O2)C(C)=C1O,,"(2S)â€3â€(4â€{[(2S)â€6â€hydroxyâ€2,5,7,8â€tetramethylâ€3,4â€dihydroâ€1â€benzopyranâ€2â€yl]methoxy}phenyl)â€2â€(hydroxysulfanyl)propanecarbonyl isocyanate",CC1=C(C)C2=C(CCC(C)(COC3=CC=C(CC(SO)C(=O)N=C=O)C=C3)O2)C(C)=C1O,,CYP3A4,0.73,"2,4-thiazolidinedione ring opening"
(s)-hexobarbital,CN1C(=O)N=C(O)C(C)(C2=CCCCC2)C1=O,,3'-OH-(S)-hexobarbital,CN1C(=O)N=C(O)C(C)(C2=CC(O)CCC2)C1=O,,CYP2C9; CYP2C19,0.95,Allylic hydroxylation
11_oxo_delta8_tetrahydrocannabinol,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC=C(C=O)CC21,,,CCCCCC1=CC(O)=C2C(=C1)OC(C)(C)C1CC=C(C(=O)O)CC21,,CYP2C8;CYP2C9;CYP2C19;CYP3A4,0.95,Aliphatic Hydroxylation
3-methylindole,CC1=CNC2=CC=CC=C12,,3-methyleneindolenine,C=C1C=[NH+]C2=CC=CC=C12,,CYP2F1,0.11,Terminal desaturation
4_demethyl_olanzapine,CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCNCC2)S1,,,CC1=CC2=C(NC3=CC=CC=C3N=C2N2CCNCC2O)S1,,CYP2D6,0.92,Aliphatic Hydroxylation
7-ethoxyresorufin,CCOC1=CC=C2N=C3C=CC(=O)C=C3OC2=C1,,Resorufin,O=C1C=CC2=NC3=CC=C(O)C=C3OC2=C1,,CYP1A2; CYP1A1,0.93,O-aryl dealkylation not adjacent to substituted carbon
biochanin a,COC1=CC=C(C2=COC3=CC(O)=CC(O)=C3C2=O)C=C1,,,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC(O)=C12,,CYP1A2;CYP2C9;CYP2C19; CYP2D6; CYP2E1,0.96,O-Demethylation
Mequitazine,C1=CC=C2C(=C1)SC1=CC=CC=C1N2CC12CCN(CC1)CC2,,,OC1=CC=C2C(=C1)SC1=CC=CC=C1N2CC12CCN(CC1)CC2,,CYP2D6,0.89,Aromatic Hydroxylation
"2Ã¢â‚¬Â[(S)Ã¢â‚¬Â[4Ã¢â‚¬Â(cyclopropylmethoxy)pyridinÃ¢â‚¬Â2Ã¢â‚¬Âyl]methanesulfinyl]Ã¢â‚¬Â5Ã¢â‚¬ÂfluoroÃ¢â‚¬Â1HÃ¢â‚¬Â1,3Ã¢â‚¬Âbenzodiazole",O=S(CC1=CC(OCC2CC2)=CC=N1)C1=NC2=CC=C(F)C=C2N1,,Sulphone,O=S(=O)(CC1=CC(OCC2CC2)=CC=N1)C1=NC2=CC=C(F)C=C2N1,,CYP1A2;CYP2C9;CYP3A4,0.93,S-Oxidation
KR-33028,N#CC1=CC=CC2=C1C=C(C(=O)NC(=N)N)S2,,5-hydroxy-KR-33028,N#CC1=C(O)C=CC2=C1C=C(C(=O)NC(=N)N)S2,,CYP3A4,0.87,Aromatic Hydroxylation
clotiazepam,CCC1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl,,Hydroxy-clotiazepam,CC(O)C1=CC2=C(S1)N(C)C(=O)CN=C2C1=CC=CC=C1Cl,,CYP2B6;CYP3A4;CYP2C18;CYP2C19,0.94,Aliphatic Hydroxylation
cotinine,CN1C(=O)CCC1C1=CC=CN=C1,,trans-3'-hydroxycotinine,CN1C(=O)C(O)CC1C1=CC=CN=C1,,CYP2A6,0.8,Hydroxylation of heteroalicyclic secondary carbon
decursinol angelate,CC=C(C)C(=O)OC1CC2=CC3=C(C=C2OC1(C)C)OC(=O)C=C3,,,CC1OC1(C)C(=O)OC1CC2=CC3=C(C=C2OC1(C)C)OC(=O)C=C3,,CYP2A6,0.86,Epoxidation
deoxypodophyllotoxin,COC1=CC(C2C3=CC4=C(C=C3CC3COC(=O)C32)OCO4)=CC(OC)=C1OC,,,COC1=CC(C2C3=CC(O)=C(O)C=C3CC3COC(=O)C32)=CC(OC)=C1OC,,CYP2C19;CYP3A4,0.96,O-Demethylation
Diazinon,CCOP(=S)(OCC)OC1=CC(C)=NC(C(C)C)=N1,,Pyrimidinol,CC1=CC(O)=NC(C(C)C)=N1,,CYP2C19,0.48,Dearylation of organphosphosulfur compound
domperidone,OC1=NC2=CC=CC=C2N1CCCN1CCC(N2C(O)=NC3=CC(Cl)=CC=C32)CC1,,,OC1=CC=C2C(=C1)N=C(O)N2CCCN1CCC(N2C(O)=NC3=CC(Cl)=CC=C32)CC1,,CYP1A2;CYP2B6;CYP2C8;CYP2D6;CYP3A4,0.9,Aromatic Hydroxylation
esomeprazole,COC1=CC=C2N=C(S(=O)CC3=NC=C(C)C(OC)=C3C)NC2=C1,,5-Hydroxyomeprazole ,COC1=CC=C2N=C(S(=O)CC3=NC=C(CO)C(OC)=C3C)NC2=C1,,CYP2C19 ,0.94,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
estrone,CC12CCC3C4=CC=C(O)C=C4CCC3C1CCC2=O,,2-OH-estrone,CC12CCC3C4=CC(O)=C(O)C=C4CCC3C1CCC2=O,,CYP3A4; CYP3A5; CYP3A7; CYP1A2; CYP2B6; CYP2C8; CYP2C9; CYP2C19; CYP2D6,0.96,Aromatic hydroxylation of fused benzene ring
flucloxacillin,CC1=C(C(O)=NC2C(=O)N3C2SC(C)(C)C3C(=O)O)C(C2=C(F)C=CC=C2Cl)=NO1,,,CC1(C)SC2C(N=C(O)C3=C(CO)ON=C3C3=C(F)C=CC=C3Cl)C(=O)N2C1C(=O)O,,CYP3A4,0.99,Aliphatic Hydroxylation
formononetin,COC1=CC=C(C2=COC3=CC(O)=CC=C3C2=O)C=C1,,Daidzein,O=C1C(C2=CC=C(O)C=C2)=COC2=CC(O)=CC=C12,,CYP1A2,0.96,O-aryl dealkylation not adjacent to substituted carbon
ibrolipim,CCOP(=O)(CC1=CC=C(C(O)=NC2=CC=C(Br)C=C2C#N)C=C1)OCC,,,CCOP(=O)(O)CC1=CC=C(C(O)=NC2=CC=C(Br)C=C2C#N)C=C1,,CYP2C8;CYP3A4,0.96,O-DEETHYLATION
kaempferide,COC1=CC=C(C2=C(O)C(=O)C3=C(O)C=C(O)C=C3O2)C=C1,,4'-OH-galangin,O=C1C(O)=C(C2=CC=C(O)C=C2)OC2=CC(O)=CC(O)=C12,,CYP1A2 ; CYP2C9,0.98,O-aryl demethylation
morphine,CN1CC2CC3=CC=C(O)C4=C3C3(C1)C2C=CC(O)C3O4,,Normorphine,OC1=CC=C2CC3CNCC45C2=C1OC4C(O)C=CC35,,CYP2C8;CYP3A4,0.98,O-Demethylation
n-(2-phenylethyl)indomethacin amide,COC1=CC=C2C(=C1)C(CC(O)=NCCC1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,,COC1=CC=C2C(=C1)C(CC(O)=NCC(O)C1=CC=CC=C1)=C(C)N2C(=O)C1=CC=C(Cl)C=C1,,CYP2C19;CYP3A4,0.97,Aliphatic Hydroxylation
nordiazepam,OC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=NC1,,OXAZEPAM,OC1=NC2=CC=C(Cl)C=C2C(C2=CC=CC=C2)=NC1O,,CYP1A2;CYP2C19;CYP3A4,0.87,Aliphatic Hydroxylation
schembl14141926,COC(=O)C(C1=CC=CC=C1Cl)N1CCC2=C(CC(=O)S2)C1,,,COC(=O)C(C1=CC=CC=C1Cl)N1CCC(S)=C(CC=O)C1,,CYP2B6;CYP2C9;CYP2C19;CYP3A4,0.87,Unknown reaction
senecionine,CC=C1CC(C)C(C)(O)C(=O)OCC2=CCN3CCC(OC1=O)C23,,"(Ã‚Â± )-6,7-dmydn>7-hydroxy-l-hydroxymethyl-5J/-pyrrolizine (DHP)",CC=C1CC(C)C(C)(O)C(=O)OCC2=CCN3CCC(OC1=O)C23O,,CYP3A4,0.82,Aliphatic Hydroxylation
serotonin,NCCC1=CNC2=CC=C(O)C=C12,,,CCC1=CNC2=CC=C(O)C=C12,,CYP2B6 (major); CYP2C19; CYP2D6; CYP1A2; CYP2C9; CYP3A4,0.92,Unknown Reduction
tangeretin,COC1=CC=C(C2=CC(=O)C3=C(OC)C(OC)=C(OC)C(OC)=C3O2)C=C1,,,COC1=CC=C(C2=CC(=O)C3=C(O)C(O)=C(OC)C(OC)=C3O2)C=C1,,CYP3A4,0.96,O-dealkylation
tauromustine,CN(C)S(=O)(=O)CCN=C(O)N(CCCl)N=O,,,CNS(=O)(=O)CCN=C(O)N(CCCl)N=O,,CYP1A2;CYP2C9;CYP2C19;CYP2D6;CYP3A4,0.94,N-Dealkylation
tolbutamide,CCCCN=C(O)NS(=O)(=O)C1=CC=C(C)C=C1,,4-Hydroxytolbutamide,CCCCN=C(O)NS(=O)(=O)C1=CC=C(CO)C=C1,,CYP2C9; CYP2C19,0.94,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
torasemide,CC1=CC=CC(N=C2C=CNC=C2S(=O)(=O)NC(O)=NC(C)C)=C1,,"N-[(4-{[3-(hydroxymethyl)phenyl]imino}-1,4-dihydropyridin-3-yl)sulfonyl]propane-2-carbamimidic acid",CC(C)N=C(O)NS(=O)(=O)C1=CNC=CC1=NC1=CC=CC(CO)=C1,,CYP2C9,0.96,Aliphatic hydroxylation of methyl carbon adjacent to aromatic ring
R-Tolperisone,CC1=CC=C(C(=O)C(C)CN2CCCCC2)C=C1,,hydroxymethyl-tolperisone,CC(CN1CCCCC1)C(=O)C1=CC=C(CO)C=C1,,CYP1A2;CYP2C19;CYP2D6,0.92,Aliphatic Hydroxylation
Alvameline,CCN1N=NC(C2=CCCN(C)C2)=N1,,,CCN1N=NC(C2=CCCNC2)=N1,,CYP1A2;CYP2A6;CYP2C19;CYP3A4,0.92,N-demethylation
Terbutryn,CCN=C1N=C(NC(C)(C)C)NC(SC)=N1,,,CCN=C1N=C(NC(C)(C)C)NC(S(C)=O)=N1,,CYP1A2;CYP2B6;CYP3A4,0.83,S-Oxidation
"7,8-Dihydrobenzo[a]pyrene-7,8-diol",OC1C=CC2=C(C=C3C=CC4=CC=CC5=CC=C2C3=C45)C1O,,,OC1C2=CC3=CC=C4C=CC=C5C=CC(=C2C2OC2C1O)C3=C45,,CYP1A1;CYP1B1,0.47,Epoxidation
L-775606,FC1=CC=CC(CCN2CCN(CCCC3=CNC4=CC=C(N5C=NN=C5)C=C34)CC2)=C1,,,OC(CN1CCN(CCCC2=CNC3=CC=C(N4C=NN=C4)C=C23)CC1)C1=CC=CC(F)=C1,,CYP3A4;CYP2C8,0.92,Aliphatic Hydroxylation
Bufuralol,CCC1=CC=CC2=C1OC(C(O)CNC(C)(C)C)=C2,,4-Hydroxybufuralol,CCC1=CC=C(O)C2=C1OC(C(O)CNC(C)(C)C)=C2,,CYP1A2; CYP2D6,0.8,Aromatic hydroxylation of fused benzene ring
Droloxifene,CCC(=C(C1=CC=C(OCCN(C)C)C=C1)C1=CC=CC(O)=C1)C1=CC=CC=C1,,,CCC(=C(C1=CC=C(OCCNC)C=C1)C1=CC=CC(O)=C1)C1=CC=CC=C1,,CYP2D6;CYP3A4,0.98,N-Dementhylation
zinc1698316,COC(=O)C1C(O)CCC2CN3CCC4=C(NC5=CC=CC=C45)C3CC21,,,COC(=O)C1C(O)CCC2CN3CCC4=C(NC5=CC=C(O)C=C45)C3CC21,,CYP2D6;CYP3A4,0.96,Aromatic Hydroxylation
zinc38309998,CCC(C)(C)C(=O)OC1CC(C)C=C2C=CC(C)C(CCC(O)CC(O)CC(=O)O)C21,,,C=C1C=C2C=CC(C)C(CCC(O)CC(O)CC(=O)O)C2C(OC(=O)C(C)(C)CC)C1,,CYP2C8;CYP3A4;CYP3A5,0.93,Dehydrogenation
zolmitriptan,CN(C)CCC1=CNC2=CC=C(CC3COC(O)=N3)C=C12,,N-Desmethylzolmitriptan,CNCCC1=CNC2=CC=C(CC3COC(O)=N3)C=C12,,CYP1A2,0.98,N-dealkylation of acyclic tertiary amine
bromperidol,O=C(CCCN1CCC(O)(C2=CC=C(Br)C=C2)CC1)C1=CC=C(F)C=C1,,,OC1(C2=CC=C(Br)C=C2)CCNCC1,,CYP3A4,0.66,N-Dealkylation
Troleandomycin,COC1CC(OC2C(C)C(=O)OC(C)C(C)C(OC(C)=O)C(C)C(=O)C3(CO3)CC(C)C(OC3OC(C)CC(N(C)C)C3OC(C)=O)C2C)OC(C)C1OC(C)=O,,,CNC1CC(C)OC(OC2C(C)CC3(CO3)C(=O)C(C)C(OC(C)=O)C(C)C(C)OC(=O)C(C)C(OC3CC(OC)C(OC(C)=O)C(C)O3)C2C)C1OC(C)=O,,CYP3A4;CYP3A5,0.97,N-Dementhylation
"(r)-chloroquine, N-desethyl",CCNCCCC(C)NC1=CC=NC2=CC(Cl)=CC=C12,,"(r)-chloroquine, N-desethyl",CC(CCCN)NC1=CC=NC2=CC(Cl)=CC=C12,,CYP2C8; CYP2D6; CYP3A4; CYP3A5,0.96,N-dealkylation of acyclic secondary amine
3'-HPPH,OC1=NC(C2=CC=CC=C2)(C2=CC=CC(O)=C2)C(O)=N1,,"3Ã¢â‚¬â„¢,4Ã¢â‚¬â„¢- diHPPH",OC1=NC(C2=CC=CC=C2)(C2=CC=C(O)C(O)=C2)C(O)=N1,,CYP2C9; CYP2C19,0.94,Hydroxylation of benzene on carbon orhto to a strongly electron donating group
7-Methoxyresorufin,COC1=CC=C2N=C3C=CC(=O)C=C3OC2=C1,,Resorufin,O=C1C=CC2=NC3=CC=C(O)C=C3OC2=C1,,CYP1A1; CYP1A2,0.95,O-aryl demethylation
Alachlor,CCC1=CC=CC(CC)=C1N(COC)C(=O)CCl,,,CCC1=CC=CC(CC)=C1N=C(O)CCl,,CYP2B6; CYP3A4,0.31,N-dealkoxylation of N-aryl-N-chloroacetamide
D-702,COC1=CC(CCN(C)CCCC(C#N)(C2=CC=C(OC)C(OC)=C2)C(C)C)=CC=C1O,,,COC1=CC=C(C(C#N)(CCCN)C(C)C)C=C1OC,,CYP3A4; CYP3A5,0.86,N-dealkylation of acyclic tertiary amine
Lithocholic Acid,CC(CCC(=O)O)C1CCC2C3CCC4CC(O)CCC4(C)C3CCC12C,,6ÃŽÂ±-Hydroxylithocholic acid,CC(CCC(=O)O)C1CCC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C,,CYP3A4,0.79,Hydroxylation of alicyclic secondary carbon
N-Desmethylmianserin,C1=CC=C2C(=C1)CC1=CC=CC=C1N1CCNCC21,,"(R)-mianserin, 8-OH-N-desmethyl",OC1=CC=C2CC3=CC=CC=C3C3CNCCN3C2=C1,,CYP2D6; CYP1A2; CYP3A4,0.92,Aromatic hydroxylation of fused benzene ring
Pranidipine,COC(=O)C1=C(C)NC(C)=C(C(=O)OCC=CC2=CC=CC=C2)C1C1=CC=CC([N+](=O)[O-])=C1,,Dehydrogenated pranidipine,COC(=O)C1=C(C)N=C(C)C(C(=O)OCC=CC2=CC=CC=C2)=C1C1=CC=CC([N+](=O)[O-])=C1,,CYP3A4,0.37,"Dehydrogenation of 4-aryl substituted 1,4-dihydropyridine"
Medroxyprogesterone Acetate,CC(=O)OC1(C(C)=O)CCC2C3CC(C)C4=CC(=O)CCC4(C)C3CCC21C,,M-4,CC(=O)OC1(C(C)=O)CCC2C3CC(C)C4=CC(=O)C(O)CC4(C)C3CCC21C,,CYP3A4;,0.92,Aliphatic Hydroxylation
"3,4-Diphenyl-7-hydroxycoumarin",O=C1OC2=CC(O)=CC=C2C(C2=CC=CC=C2)=C1C1=CC=CC=C1,,"3,4-Diphenyl-7-hydroxycoumarin, 7-OH-glucuronide",O=C(O)C1OC(OC2=CC=C3C(C4=CC=CC=C4)=C(C4=CC=CC=C4)C(=O)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.65,Aromatic -OH glucuronidation
4-hydroxyestrone,CC12CCC3C4=CC=C(O)C(O)=C4CCC3C1CCC2=O,,Estrone 4-O-glucuronide,CC12CCC3C4=CC=C(O)C(OC5OC(C(=O)O)C(O)C(O)C5O)=C4CCC3C1CCC2=O,,UGT1A1; UGT1A3; UGT1A7; UGT1A8; UGT1A10,0.56,Aromatic -OH glucuronidation
"dibenzo[a,l]pyrene-11,12- diol",OC1=CC=C2C(=C1O)C=C1C=CC3=CC=CC4=C5C=CC=CC5=C2C1=C34,,"dibenzo[a,l]pyrene-11-ol, 12-O-glucuronide",O=C(O)C1OC(OC2=CC=C3C(=C2O)C=C2C=CC4=CC=CC5=C6C=CC=CC6=C3C2=C45)C(O)C(O)C1O,,UGT1A1; UGT1A4,0.18,Aromatic -OH glucuronidation
"4-hydroxy-2p,3,5-trichlorobiphenyl",OC1=C(Cl)C=C(C2=CC=CC=C2Cl)C=C1Cl,,"2p,3,5-trichlorobiphenyl, 4-sulfate",O=S(=O)(O)OC1=C(Cl)C=C(C2=CC=CC=C2Cl)C=C1Cl,,SULT1A2,0.65,4-OH sulfonation of phenolic compound
8-Hydroxynevirapine,CC1=CC=NC2=C1N=C(O)C1=CC(O)=CN=C1N2C1CC1,,8-Hydroxynevirapine O-glucuronide,CC1=CC=NC2=C1N=C(O)C1=CC(OC3OC(C(=O)O)C(O)C(O)C3O)=CN=C1N2C1CC1,,UGT,0.82,Aromatic -OH glucuronidation
3-Hydroxynevirapine,CC1=C(O)C=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,3-Hydroxynevirapine O-glucuronide,CC1=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=NC2=C1N=C(O)C1=CC=CN=C1N2C1CC1,,UGT,0.82,Aromatic -OH glucuronidation
Aminoflavone M-II,CC1=C(F)C(NO)=C2C(=O)C=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,Aminoflavone M-II O-glucuronide,CC1=C(F)C(NOC2OC(C(=O)O)C(O)C(O)C2O)=C2C(=O)C=C(C3=CC=C(N)C(F)=C3)OC2=C1F,,UGT,0.79,O-glucuronidation
Aminoflavone M-V,CC1=C(F)C(NO)=C2C(=O)C=C(C3=CC=C(NO)C(F)=C3)OC2=C1F,,Aminoflavone M-V O-sulfate,CC1=C(F)C(NOS(=O)(=O)O)=C2C(=O)C=C(C3=CC=C(NO)C(F)=C3)OC2=C1F,,SULT,0.94,O-sulfonation
2‐(pyren‐1‐yl)ethanol,OCCC1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,,O=S(=O)(O)OCCC1=CC=C2C=CC3=CC=CC4=CC=C1C2=C34,,SULT1A1; SULT1A2; SULT1C1; SULT1C2; SULT1C3; SULT1E1; SULT2A1,0.73,Sulfation of primary alcohol
Diphenylamine,C1=CC=C(NC2=CC=CC=C2)C=C1,,Diphenylamine N-glucuronide,O=C(O)C1OC(N(C2=CC=CC=C2)C2=CC=CC=C2)C(O)C(O)C1O,,UGT1A3,0.1,N-glucuronidation
Indacaterol,CCC1=CC2=C(C=C1CC)CC(NCC(O)C1=CC=C(O)C3=NC(O)=CC=C13)C2,,,CCC1=CC2=C(C=C1CC)CC(NCC(OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=C(O)C3=NC(O)=CC=C13)C2,,UGT,0.66,O-glucuronidation
"8-aminoisoindolo (1,2-b)quinazolin-12(10H)-one",NC1=CC=C2N=C3C4=CC=CC=C4C(=O)N3CC2=C1,,,CC(O)=NC1=CC=C2N=C3C4=CC=CC=C4C(=O)N3CC2=C1,,NAT,0.94,N-acetylation of arylamine
"5,7,2p-Trihydroxyflavone",O=C1C=C(C2=CC=CC=C2O)OC2=CC(O)=CC(O)=C12,,,O=C(O)C1OC(OC2=CC(O)=C3C(=O)C=C(C4=CC=CC=C4O)OC3=C2)C(O)C(O)C1O,,UGT1A9,0.63,Aromatic -OH glucuronidation
FYX-051,N#CC1=CC(C2=NC(C3=CC=NC=C3)=NN2)=CC=N1,,,N#CC1=CC(C2=NN(C3OC(C(=O)O)C(O)C(O)C3O)C(C3=CC=NC=C3)=N2)=CC=N1,,UGT1A9,0.32,N-glucuronidation of azole
10-hydroxycarbazepine,N=C(O)N1C2=CC=CC=C2CC(O)C2=CC=CC=C21,,,N=C(O)N1C2=CC=CC=C2CC(OC2OC(C(=O)O)C(O)C(O)C2O)C2=CC=CC=C21,,UGT,0.6,Alkyl-OH glucuronidation
6-Hydroxymelatonin,COC1=CC2=C(C=C1O)NC=C2CCN=C(C)O,,,COC1=CC2=C(C=C1OC1OC(C(=O)O)C(O)C(O)C1O)NC=C2CCN=C(C)O,,UGT,0.57,Aromatic -OH glucuronidation
N-OH-ABA,O=C1C2=CC=CC=C2C2=C3C1=CC=CC3=C(NO)C=C2,,,O=C1C2=CC=CC=C2C2=C3C1=CC=CC3=C(NOS(=O)(=O)O)C=C2,,"SULT1A1, SULT1A2",0.93,O-sulfonation
Thalifendine,COC1=CC=C2C=C3C4=CC5=C(C=C4CC[NH+]3C=C2C1=O)OCO5,,,COC1=CC=C2C=C3C4=CC5=C(C=C4CC[N+]3=CC2=C1OC1OC(C(=O)O)C(O)C(O)C1O)OCO5,,UGT,0.53,O-glucuronidation
"(R,R)-1-phenylpropylene oxide",CC1OC1C1=CC=CC=C1,,,NC(CCC(O)=NC(CSCC1OC1C1=CC=CC=C1)C(O)=NCC(=O)O)C(=O)O,,GST,0.31,GSH-conjugation of epoxide
4-Iodophenol,OC1=CC=C(I)C=C1,,,O=C(O)C1OC(OC2=CC=C(I)C=C2)C(O)C(O)C1O,,UGT1A9,0.1,O-glucuronidation
Dezocine,CC12CCCCCC(CC3=CC=C(O)C=C31)C2N,,,CC12CCCCCC(CC3=CC=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=C31)C2N,,UGT,0.59,O-glucuronidation
Hydroxyfarnesol,CC(=CCCC(C)=CCCC(C)=CCO)CO,,,CC(=CCO)CCC=C(C)CCC=C(C)COC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.15,O-glucuronidation
Dihydromorphine,CN1CCC23C4=C5C=CC(O)=C4OC2C(O)CCC3C1C5,,,CN1CCC23C4=C5C=CC(OC6OC(C(=O)O)C(O)C(O)C6O)=C4OC2C(O)CCC3C1C5,,UGT,0.87,O-glucuronidation
N-hydroxy-2-acetylaminofluorene,CC(=O)N(O)C1=CC=C2C(=C1)CC1=CC=CC=C12,,,CC(=O)N(OC1OC(C(=O)O)C(O)C(O)C1O)C1=CC=C2C(=C1)CC1=CC=CC=C12,,"UGT1A4, 1A6",0.51,O-glucuronidation
N-hydroxy-2-aminobenzanthrone,O=C1C=C2C=C3C=CC4=CC=C(NO)C=C4C3=CC2=CC1,,,O=C1C=C2C=C3C=CC4=CC=C(NOC5OC(C(=O)O)C(O)C(O)C5O)C=C4C3=CC2=CC1,,SULT1A1,0.45,O-sulfonation
Misonidazole,COCC(O)CN1C=CN=C1[N+](=O)[O-],,,COCC(CN1C=CN=C1[N+](=O)[O-])OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.51,O-glucuronidation
Etiocholanolone,CC12CCC3C(CCC4CC(O)CCC43C)C1CCC2=O,,,CC12CCC3C(CCC4CC(OC5OC(C(=O)O)C(O)C(O)C5O)CCC43C)C1CCC2=O,,UGT,0.35,O-glucuronidation
Lumiracoxib M25,CC1=CC=C2C(=C1)CC(=O)N2C1=C(F)C=C(O)C=C1Cl,,,CC1=CC=C2C(=C1)CC(=O)N2C1=C(F)C=C(OC2OC(C(=O)O)C(O)C(O)C2O)C=C1Cl,,UGT,0.73,O-glucuronidation
"2,3-Dihydroxynaphthalene",OC1=CC2=CC=CC=C2C=C1O,,,COC1=CC2=CC=CC=C2C=C1O,,COMT,0.69,O-methylation
3-Hydroxy-4-aminopyridine,N=C1C=CNC=C1O,,,N=C1C=CNC=C1OS(=O)(=O)O,,SULT,0.41,O-sulfonation
Caffeic Acid,O=C(O)C=CC1=CC=C(O)C(O)=C1,,,O=C(O)C=CC1=CC=C(OC2OC(C(=O)O)C(O)C(O)C2O)C(O)=C1,,UGT1A9,0.28,O-glucuronidation
Ferulic Acid,COC1=CC(C=CC(=O)O)=CC=C1O,,,COC1=CC(C=CC(=O)O)=CC=C1OC1OC(C(=O)O)C(O)C(O)C1O,,UGT1A9,0.33,O-glucuronidation
"5-Hydroxy, 6-methoxy duloxetine",CNCCC(OC1=CC=CC2=C(O)C(OC)=CC=C12)C1=CC=CO1,,,CNCCC(OC1=CC=CC2=C(OS(=O)(=O)O)C(OC)=CC=C12)C1=CC=CO1,,SULT,0.8,O-sulfonation
4-Phenylazophenol,OC1=CC=C(N=NC2=CC=CC=C2)C=C1,,,O=C(O)C1OC(OC2=CC=C(N=NC3=CC=CC=C3)C=C2)C(O)C(O)C1O,,UGT1A9,0.18,O-glucuronidation
O-Desmethyl-tramado,CN(C)CC1CCCCC1(O)C1=CC=CC(O)=C1,,,CN(C)CC1CCCCC1(O)C1=CC=CC(OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.56,O-glucuronidation
Magnolol,C=CCC1=CC=C(O)C(C2=CC(CC=C)=CC=C2O)=C1,,,C=CCC1=CC=C(O)C(C2=CC(CC=C)=CC=C2OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.36,O-glucuronidation
cumene hydroperoxide,CC(C)(OO)C1=CC=CC=C1,,,CC(C)(OOSCC(N=C(O)CCC(N)C(=O)O)C(O)=NCC(=O)O)C1=CC=CC=C1,,GST,0.27,GSH-conjugation
O-Desmethylgalantamine,CN1CCC23C=CC(O)CC2OC2=C(O)C=CC(=C23)C1,,,CN1CCC23C=CC(O)CC2OC2=C(OC4OC(C(=O)O)C(O)C(O)C4O)C=CC(=C23)C1,,UGT,0.86,O-glucuronidation
N-Oxide abiraterone,CC12CCC(O)CC1=CCC1C2CCC2(C)C(C3=CC=C[N+]([O-])=C3)=CCC12,,,CC12CCC(OS(=O)(=O)O)CC1=CCC1C2CCC2(C)C(C3=CC=C[N+]([O-])=C3)=CCC12,,SULT,0.9,O-sulfonation
"(1-methyl-5-piperazin-1-yl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)-(5-methyl-pyridin-2-yl)-amine",CCCC1=NN(C)C2=C(NC3=CC=C(C)C=N3)N=C(N3CCNCC3)N=C12,,,CCCC1=NN(C)C2=C(NC3=CC=C(C)C=N3)N=C(N3CCN(C(C)=O)CC3)N=C12,,NAT,0.97,N-acetylation
Thienorphine,COC12CCC3(CC1C(C)(O)CCC1=CC=CS1)C1CC4=CC=C(O)C5=C4C3(CCN1CC1CC1)C2O5,,,COC12CCC3(CC1C(C)(O)CCC1=CC=CS1)C1CC4=CC=C(OC5OC(C(=O)O)C(O)C(O)C5O)C5=C4C3(CCN1CC1CC1)C2O5,,UGT,0.92,O-glucuronidation
Mexiletine alcohol,CC1=CC=CC(C)=C1OCC(C)O,,,CC1=CC=CC(C)=C1OCC(C)OC1OC(C(=O)O)C(O)C(O)C1O,,UGT,0.34,O-glucuronidation
4-OH-S-flurbiprofen,CC(C(=O)O)C1=CC=C(C2=CC=C(O)C=C2)C(F)=C1,,,CC(C(=O)O)C1=CC=C(C2=CC=C(OC3OC(C(=O)O)C(O)C(O)C3O)C=C2)C(F)=C1,,UGT,0.48,O-glucuronidation
3-Hydroxy-6-methoxyflavone,COC1=CC=C2OC(C3=CC=CC=C3)=C(O)C(=O)C2=C1,,,COC1=CC=C2OC(C3=CC=CC=C3)=C(OC3OC(C(=O)O)C(O)C(O)C3O)C(=O)C2=C1,,UGT1A9,0.59,O-glucuronidation
Gemfibrozil,CC1=CC=C(C)C(OCCCC(C)(C)C(=O)O)=C1,,,CC1=CC=C(C)C(OCCCC(C)(C)C(=O)OC2OC(C(=O)O)C(O)C(O)C2O)=C1,,UGT,0.41,O-glucuronidation
Tetrahydrodaidzein,OC1=CC=C(C2COC3=CC(O)=CC=C3C2O)C=C1,,Equol,OC1=CC=C(C2COC3=CC(O)=CC=C3C2)C=C1,,Unspecified gut bacterial enzyme,0.76,Isoflavan-4-ol dehydroxylation
